Excessive oxidative stress is always associated with the serious side effects of
chemotherapy. In the current study, we developed a
vitamin E based strongly reductive nanosystem to increase the loading efficiency of
docetaxel (DTX, DTX-VNS), reduce its side toxicity and enhance the antitumor effect. Methods: We used Förster Resonance Energy Transfer (FRET) to reveal the in vivo and in vitro fate of DTX-VNS over time. All FRET images were observed using the Maestro imaging system (CRI, Inc., Woburn, MA) and Fluo-View software (Olympus LX83-FV3000). Results: Through FRET analyzing, we found that our nanosystem showed a selective rapider release of drugs in
tumors compared to normal organs due to the higher levels of ROS in
tumor cells than normal cells, and the accumulation of DTX at
tumor sites in the DTX-VNS group was also notably more than that in the
Taxotere group after 24 h injection. Meanwhile, DTX-VNS had a prominently stronger anti-
tumor effect in various models than
Taxotere, and had a synergistic effect of
immunotherapy. Conclusions: Our work presented a useful reference for clinical exploration of the in vivo behavior of nanocarriers (DTX-VNS), inhibition oxidative stress and selective release of drugs at
tumor sites, thus reducing the side effects and enhancing the anti-
tumor effects.